PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Dagmar Kollmann; Desislava Ignatova; Julia Jedamzik; Yun-Tsan Chang; Gerd Jomrich; Andreas Baierl; Dmitry Kazakov; Michal Michal; Lars E. French; Wolfram Hötzenecker; Tobias Schatton; Reza Asari; Matthias Preusser; Michael Gnant; Emmanuella Guenova; Sebastian F. Schoppmann

doi:10.1080/2162402X.2018.1435226

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Dagmar Kollmann
, Desislava Ignatova
, Julia Jedamzik
, Yun-Tsan Chang
, Gerd Jomrich
, Andreas Baierl
, Dmitry Kazakov
, Michal Michal
, Lars E. French
, Wolfram Hötzenecker
, Tobias Schatton
, Reza Asari
, Matthias Preusser
, Michael Gnant
, Emmanuella Guenova
, Sebastian F. Schoppmann

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e1435226
Journal	OncoImmunology
Volume	7
Issue number	6
DOIs	https://doi.org/10.1080/2162402X.2018.1435226
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

JKU Focus areas

Medical Sciences (in general)
Health System Research
Clinical Research on Aging

Access to Document

10.1080/2162402X.2018.1435226

Cite this

Kollmann, D., Ignatova, D., Jedamzik, J., Chang, Y.-T., Jomrich, G., Baierl, A., Kazakov, D., Michal, M., French, L. E., Hötzenecker, W., Schatton, T., Asari, R., Preusser, M., Gnant, M., Guenova, E., & Schoppmann, S. F. (2018). PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma. OncoImmunology, 7(6), Article e1435226. https://doi.org/10.1080/2162402X.2018.1435226

@article{79b14c610f914aa5a58c56d82add0111,

title = "PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma",

author = "Dagmar Kollmann and Desislava Ignatova and Julia Jedamzik and Yun-Tsan Chang and Gerd Jomrich and Andreas Baierl and Dmitry Kazakov and Michal Michal and French, \{Lars E.\} and Wolfram H{\"o}tzenecker and Tobias Schatton and Reza Asari and Matthias Preusser and Michael Gnant and Emmanuella Guenova and Schoppmann, \{Sebastian F.\}",

year = "2018",

doi = "10.1080/2162402X.2018.1435226",

language = "English",

volume = "7",

journal = "OncoImmunology",

issn = "2162-402X",

number = "6",

}

Kollmann, D, Ignatova, D, Jedamzik, J, Chang, Y-T, Jomrich, G, Baierl, A, Kazakov, D, Michal, M, French, LE, Hötzenecker, W, Schatton, T, Asari, R, Preusser, M, Gnant, M, Guenova, E & Schoppmann, SF 2018, 'PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma', OncoImmunology, vol. 7, no. 6, e1435226. https://doi.org/10.1080/2162402X.2018.1435226

TY - JOUR

T1 - PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

AU - Kollmann, Dagmar

AU - Ignatova, Desislava

AU - Jedamzik, Julia

AU - Chang, Yun-Tsan

AU - Jomrich, Gerd

AU - Baierl, Andreas

AU - Kazakov, Dmitry

AU - Michal, Michal

AU - French, Lars E.

AU - Hötzenecker, Wolfram

AU - Schatton, Tobias

AU - Asari, Reza

AU - Preusser, Matthias

AU - Gnant, Michael

AU - Guenova, Emmanuella

AU - Schoppmann, Sebastian F.

PY - 2018

Y1 - 2018

UR - https://www.ncbi.nlm.nih.gov/pubmed/29872575

U2 - 10.1080/2162402X.2018.1435226

DO - 10.1080/2162402X.2018.1435226

M3 - Article

SN - 2162-402X

VL - 7

JO - OncoImmunology

JF - OncoImmunology

IS - 6

M1 - e1435226

ER -

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

UN SDGs

Fields of science

JKU Focus areas

Access to Document

Other files and links

Cite this